Rituximab

A board to discuss future MS therapies in early stage (Phase I or II) trials.

Rituximab

Postby bromley » Tue Oct 18, 2005 12:29 pm

Rituximab (rituxan) is in Phase ii trials (Biogen is the drugs company behind rituxan).

The following research paper suggests it has benefits - it affects B cells (rather than the usual T cells)

Bromley

http://www.msif.org/en/research/researc ... tabil.html
User avatar
bromley
Family Elder
 
Posts: 1887
Joined: Fri Sep 10, 2004 3:00 pm

Advertisement

Return to Drug Pipeline

 


  • Related topics
    Replies
    Views
    Last post

Who is online

Users browsing this forum: No registered users


Contact us | Terms of Service